These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22926920)

  • 21. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
    Xu Y; Yuan J; Zhang Z; Lin L; Xu S
    Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
    Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
    J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL20/CCR6 expression profile in pancreatic cancer.
    Rubie C; Frick VO; Ghadjar P; Wagner M; Grimm H; Vicinus B; Justinger C; Graeber S; Schilling MK
    J Transl Med; 2010 May; 8():45. PubMed ID: 20459729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
    Li S; Yang B; Li G; He S; Li Y
    Brain Tumor Pathol; 2013 Jan; 30(1):8-14. PubMed ID: 22399192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
    Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
    J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.
    Tu Y; He S; Fu J; Li G; Xu R; Lu H; Deng J
    Clin Transl Oncol; 2012 Mar; 14(3):214-20. PubMed ID: 22374425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris.
    Yoshizaki T; Bandoh N; Ueda S; Nozawa H; Goto T; Kishibe K; Takahara M; Harabuchi Y
    Clin Exp Immunol; 2009 Jul; 157(1):71-82. PubMed ID: 19659772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of chemokine ligand 20 and chemokine receptor 6 in patients with sepsis: A case control study.
    Klaus DA; Seemann R; Roth-Walter F; Einwallner E; Motal MC; Tudor B; Lebherz-Eichinger D; Wiegele M; Krenn CG; Roth GA
    Eur J Anaesthesiol; 2016 May; 33(5):348-55. PubMed ID: 26771764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of FOXP3 expression in human gliomas.
    Wang L; Zhang B; Xu X; Zhang S; Yan X; Kong F; Feng X; Wang J
    Clin Transl Oncol; 2014 Jan; 16(1):36-43. PubMed ID: 23579918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor microRNA-335 expression is associated with poor prognosis in human glioma.
    Jiang J; Sun X; Wang W; Jin X; Bo X; Li Z; Bian A; Jiu J; Wang X; Liu D; Hui X; Wang Y; Wang A; Ding L
    Med Oncol; 2012 Dec; 29(5):3472-7. PubMed ID: 22644918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of chemokine receptor CCR6 as a molecular determinant of adrenal metastatic relapse in patients with primary lung cancer.
    Raynaud CM; Mercier O; Dartevelle P; Commo F; Olaussen KA; de Montpreville V; André F; Sabatier L; Soria JC
    Clin Lung Cancer; 2010 May; 11(3):187-91. PubMed ID: 20439195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
    Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
    Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro.
    Guo YF; Wang XB; Tian XY; Li Y; Li B; Huang Q; Zhang M; Li Z
    World J Surg Oncol; 2012 Jun; 10():128. PubMed ID: 22741575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined aberrant expression of microRNA-214 and UBC9 is an independent unfavorable prognostic factor for patients with gliomas.
    Wang S; Jiao B; Geng S; Ma S; Liang Z; Lu S
    Med Oncol; 2014 Jan; 31(1):767. PubMed ID: 24277415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
    Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
    Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
    Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
    J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.